INNOCAN PHARMA Corp (INNPF)
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
InnoCan Pharma Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 1.29 | 1.29 | 1.29 | 1.29 | 100 |
| Oct 23, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 100 |
| Oct 15, 2026 | 1.25 | 1.33 | 1.25 | 1.33 | 200 |
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients.
Its operations extend across the United States, Poland, France, and other international markets.
The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
100
60d Avg
143
90d Avg
131